Journal of the American Pharmacists Association : JAPhA
-
J Am Pharm Assoc (2003) · Nov 2007
Evaluation of calcium and vitamin D supplementation in bisphosphonate therapy.
To assess the calcium and vitamin D intake of osteoporosis patients on bisphosphonate therapy. ⋯ Patients do not recognize the need to supplement calcium at the recommended dosage of at least 1,200 mg/day or 1,500 mg/day for postmenopausal women with osteoporosis along with vitamin D 400 IU for osteoporosis treatment while on bisphosphonate therapy.